---
title: "Boji Medical Technology Co.,Ltd. (300404.SZ)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300404.SZ.md"
symbol: "300404.SZ"
name: "Boji Medical Technology Co.,Ltd."
industry: "Life Sciences Tools and Services"
datetime: "2026-05-20T22:33:49.284Z"
locales:
  - [en](https://longbridge.com/en/quote/300404.SZ.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300404.SZ.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300404.SZ.md)
---

# Boji Medical Technology Co.,Ltd. (300404.SZ)

## Company Overview

Boji Medical Technology Co.,Ltd. provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally. It offers pre-clinical research, clinical research, and other consulting services. The company also provides clinical drug production, pilot test scale-up, process verification batch production, and drug registration and approval services.

| Item | Detail |
|------|--------|
| Industry | Life Sciences Tools and Services |
| Exchange | CN Market |
| Website | [www.gzboji.com](https://www.gzboji.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:11.000Z

**Overall: B (0.32)**

**Industry**: Life Sciences Tools and Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 11 / 26 |
| Industry Median | B |
| Industry Average | C |

- **Style**: Growth - Stocks whose main business is in the growth stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 33.15% |  |
| Net Profit YoY | 166.36% |  |
| P/B Ratio | 3.89 |  |
| Dividend Ratio | 0.11% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 4159271282.69 |  |
| Revenue | 951628809.00 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 4.19% | C |
| Profit Margin | 4.53% | C |
| Gross Margin | 28.45% | C |
| Revenue YoY | 33.15% | A |
| Net Profit YoY | 166.36% | A |
| Total Assets YoY | 12.04% | B |
| Net Assets YoY | 8.63% | B |
| Cash Flow Margin | 155.73% | B |
| OCF YoY | 33.15% | A |
| Turnover | 0.60 | B |
| Gearing Ratio | 34.06% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Boji Medical Technology Co.,Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "33.15%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "166.36%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "3.89",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.11%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "4159271282.69",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "951628809.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "4.19%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "4.53%",
          "rating": "C"
        },
        {
          "name": "Gross Margin",
          "value": "28.45%",
          "rating": "C"
        },
        {
          "name": "Revenue YoY",
          "value": "33.15%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "166.36%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "12.04%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "8.63%",
          "rating": "B"
        },
        {
          "name": "Cash Flow Margin",
          "value": "155.73%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "33.15%",
          "rating": "A"
        },
        {
          "name": "Turnover",
          "value": "0.60",
          "rating": "B"
        },
        {
          "name": "Gearing Ratio",
          "value": "34.06%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 95.74 | 16/26 | 531.98 | 304.40 | 229.09 |
| PB | 3.86 | 20/26 | 4.06 | 3.85 | 3.64 |
| PS (TTM) | 4.34 | 5/26 | 5.39 | 5.08 | 4.78 |
| Dividend Yield | 0.11% | 17/26 | 0.12% | 0.11% | 0.11% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | WuXi AppTec (603259.SH) | A | A | C | A | B | B |
| 02 | Pharmaron (300759.SZ) | B | B | C | B | B | B |
| 03 | Chemexpress (688131.SH) | B | B | C | C | B | B |
| 04 | HitGen (688222.SH) | B | A | D | B | C | B |
| 05 | GEMPHARMATECH (688046.SH) | B | B | D | A | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2025-03-23T16:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Overweight | 1 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 10.68 |
| Highest Target | undefined |
| Lowest Target | undefined |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/300404.SZ/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/300404.SZ/norm.md)
- [Related News](https://longbridge.com/en/quote/300404.SZ/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/300404.SZ/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**